Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18652657 | REDUCED PRESSURE THERAPY SYSTEMS AND METHODS INCLUDING AN ANTENNA | May 2024 | June 2025 | Allow | 14 | 1 | 0 | No | No |
| 17944571 | Method of Removing Fluid from the Body, and Device Therefore | September 2022 | July 2024 | Allow | 22 | 0 | 0 | No | No |
| 17940380 | SYSTEM FOR SHAPING AND IMPLANTING BIOLOGIC INTRAOCULAR STENT FOR INCREASED AQUEOUS OUTFLOW AND LOWERING OF INTRAOCULAR PRESSURE | September 2022 | June 2025 | Allow | 33 | 0 | 0 | No | No |
| 17797210 | A Disposable Flushing and Suction Drainage Tube and Its Operation Method | August 2022 | May 2024 | Abandon | 22 | 2 | 0 | No | No |
| 17758096 | WRAPPING SHEET AND WRAPPED ABSORBENT ARTICLE | June 2022 | March 2025 | Abandon | 32 | 1 | 0 | No | No |
| 17785650 | SYSTEMS AND METHODS FOR OPERATING A WOUND THERAPY DEVICE IN STEALTH MODE | June 2022 | December 2024 | Allow | 30 | 2 | 0 | Yes | No |
| 17746815 | DISPOSABLE ABSORBENT ARTICLE WITH ODOR REDUCING AGENTS | May 2022 | March 2025 | Abandon | 34 | 1 | 0 | No | No |
| 17743198 | CRYSTAL INFUSED FEMININE HYGIENE WASHES | May 2022 | March 2025 | Abandon | 34 | 1 | 0 | No | No |
| 17724845 | EXTRA-LUMEN ADSORPTION OF VIRAL PATHOGENS FROM BLOOD | April 2022 | September 2024 | Abandon | 29 | 1 | 0 | No | No |
| 17767748 | BREAST PAD AND METHOD OF MANUFACTURE | April 2022 | December 2024 | Abandon | 32 | 1 | 0 | No | No |
| 17686597 | WOUND CARE DEVICE HAVING FLUID TRANSFER AND ADHESIVE PROPERTIES | March 2022 | May 2025 | Allow | 38 | 4 | 0 | No | Yes |
| 17672299 | Implant Device for Eye Disease for Adjusting Intraocular Pressure | February 2022 | July 2023 | Allow | 17 | 1 | 0 | No | No |
| 17590568 | LIQUID-INDICATING ALARM DIAPER DEVICE | February 2022 | September 2024 | Abandon | 31 | 2 | 0 | No | No |
| 17571693 | EYE DROP DISPENSER ASSEMBLY | January 2022 | January 2024 | Abandon | 25 | 2 | 0 | No | No |
| 17569929 | GLAUCOMA TREATMENT DEVICES AND METHODS | January 2022 | April 2023 | Abandon | 15 | 1 | 0 | No | No |
| 17485741 | MARROW ASPIRATION DEVICE AND METHOD OF USE | September 2021 | August 2023 | Abandon | 22 | 1 | 0 | No | No |
| 17399766 | Unisex Urine Collection Assembly | August 2021 | November 2024 | Abandon | 39 | 4 | 0 | No | Yes |
| 17417926 | MULTIFUNCTIONAL CENTRAL SUCTION SYSTEM CAPABLE OF REMOTE MONITORING | June 2021 | February 2025 | Allow | 44 | 3 | 0 | No | No |
| 17343937 | EXTREMITY IRRIGATION DEBRIDEMENT BASIN | June 2021 | May 2024 | Abandon | 35 | 4 | 0 | No | No |
| 17325785 | SYSTEM FOR SHAPING AND IMPLANTING BIOLOGIC INTRAOCULAR STENT FOR INCREASED AQUEOUS OUTFLOW AND LOWERING OF INTRAOCULAR PRESSURE | May 2021 | February 2025 | Allow | 45 | 2 | 1 | No | No |
| 17302596 | AUXILIARY BAND AND METHOD FOR SECURING AN ABSORBENT PAD ONTO A VULVA REGION | May 2021 | October 2024 | Abandon | 41 | 3 | 0 | Yes | No |
| 17306821 | Automated Fluid Output Monitoring | May 2021 | April 2024 | Allow | 36 | 2 | 0 | Yes | No |
| 17302391 | Body Cavity Access Device | April 2021 | May 2024 | Abandon | 37 | 3 | 0 | Yes | No |
| 17207718 | SYSTEMS AND METHODS FOR IMPLANTING A GASTRIC BYPASS DEVICE | March 2021 | August 2023 | Abandon | 28 | 1 | 0 | No | No |
| 17202756 | METHODS OF MONITORING URINARY CATHETER USAGE | March 2021 | July 2024 | Allow | 40 | 0 | 0 | No | No |
| 17263092 | CANNULA FOR THE DRAINAGE OF BLOOD VESSELS | January 2021 | December 2022 | Abandon | 23 | 1 | 0 | No | No |
| 17154983 | DEVICES, METHODS, AND SYSTEMS FOR IMPROVED ENEMA AND RECTAL IRRIGATION PROCEDURES | January 2021 | June 2024 | Abandon | 40 | 3 | 0 | Yes | No |
| 17151749 | Absorbent articles comprising a SBC based hotmelt adhesive | January 2021 | April 2025 | Allow | 51 | 4 | 0 | No | Yes |
| 17141009 | AlgaeAid | January 2021 | June 2023 | Abandon | 30 | 1 | 0 | No | No |
| 17254514 | Active Agent Delivery Devices and Methods for Using the Same | December 2020 | May 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17124415 | FLUID LEVEL MONITORING SYSTEM FOR PHACOEMULSIFICATION SURGICAL APPLICATIONS | December 2020 | July 2024 | Abandon | 43 | 4 | 0 | No | No |
| 17252230 | AN OSMOTIC ACTUATOR FOR AN INJECTING DEVICE AND AN INJECTION DEVICE COMPRISING SUCH AN OSMOTIC ACTUATOR | December 2020 | July 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17117297 | BIDIRECTIONAL VASCULAR CANNULA DEVICE | December 2020 | January 2023 | Allow | 25 | 1 | 0 | No | No |
| 17100309 | HAND TOOL WITH INTEGRATED MICROPUMP AND DRUG RESERVOIR FOR INTRACOCHLEAR DRUG DELIVERY | November 2020 | January 2025 | Abandon | 49 | 4 | 0 | Yes | No |
| 17050768 | AIR TRAP CHAMBER AND EXTRACORPOREAL CIRCULATION CIRCUIT | October 2020 | June 2024 | Allow | 43 | 1 | 0 | Yes | No |
| 17078641 | Hygiene Pad | October 2020 | June 2023 | Abandon | 32 | 1 | 0 | No | No |
| 17070187 | Exhalation Disposal System | October 2020 | November 2023 | Abandon | 37 | 2 | 0 | No | No |
| 17046023 | BRIDGE DRESSING WITH FLUID MANAGEMENT | October 2020 | December 2023 | Abandon | 38 | 4 | 0 | Yes | No |
| 17040406 | Complex Aqua Skin Peeling Machine | September 2020 | September 2024 | Abandon | 48 | 2 | 0 | No | No |
| 17013523 | MULTI-LAYERED DRESSING | September 2020 | January 2025 | Allow | 53 | 3 | 0 | Yes | No |
| 16965986 | IMPLANTABLE CATHETER ASSEMBLIES | July 2020 | October 2023 | Abandon | 39 | 2 | 0 | No | No |
| 16964366 | SENSOR FOR LOCATING WITHIN A URINARY DRAINAGE BAG | July 2020 | January 2024 | Abandon | 42 | 2 | 1 | No | No |
| 16955414 | IMPLANT DEVICE FOR EYE DISEASE FOR ADJUSTING INTRAOCULAR PRESSURE | June 2020 | August 2023 | Allow | 38 | 4 | 0 | Yes | No |
| 16861738 | Hygiene product in underpants form | April 2020 | April 2023 | Abandon | 36 | 1 | 0 | No | No |
| 16860517 | Respiratory Expellant Containment Pad | April 2020 | March 2023 | Abandon | 34 | 1 | 0 | No | No |
| 16647558 | URINE-DETECTION DEVICE WITH ADHESIVE TAPE AND EMITTER SENSOR | March 2020 | February 2023 | Abandon | 35 | 2 | 0 | No | No |
| 16748439 | URINARY CATHETER HAVING AN INJECTION MOLDED TIP | January 2020 | March 2025 | Abandon | 60 | 4 | 1 | No | No |
| 16491542 | REDUCED PRESSURE THERAPY SYSTEMS AND METHODS INCLUDING AN ANTENNA | September 2019 | February 2024 | Allow | 53 | 4 | 0 | Yes | No |
| 16487915 | A NOVEL FLEXIBLE MICROFLUIDIC MESHWORK FOR GLAUCOMA SURGERY | August 2019 | October 2023 | Allow | 50 | 3 | 0 | Yes | No |
| 16485240 | Expandable Percutaneous Cannula | August 2019 | February 2025 | Allow | 60 | 5 | 0 | Yes | Yes |
| 16484552 | A VENOVENOUS ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION) CANNULA | August 2019 | October 2023 | Abandon | 51 | 4 | 0 | No | No |
| 16513575 | CONVERTIBLE MULTI-STAGE / BI-CAVAL FEMORAL VENOUS CANNULA | July 2019 | December 2022 | Abandon | 41 | 2 | 0 | No | No |
| 16457857 | Cannula for minimally invasive surgical tricuspid valve repair | June 2019 | September 2024 | Abandon | 60 | 4 | 0 | No | No |
| 16445799 | SUCTION TIP FOR GENTLY SUCTIONING A BIOLOGICAL FLUID | June 2019 | March 2024 | Abandon | 57 | 4 | 0 | Yes | No |
| 16442948 | METHOD AND DEVICE FOR IMPLANTED PORT ALLEVIATION | June 2019 | July 2022 | Abandon | 37 | 1 | 0 | No | No |
| 16418729 | ARTERIAL SHEATH WHICH ALLOWS DISTAL PERFUSION WITHIN A CANNULATED VESSEL | May 2019 | March 2024 | Allow | 58 | 1 | 1 | No | No |
| 16394570 | Method of Removing Fluid from the Body, and Device Therefore | April 2019 | May 2022 | Allow | 37 | 1 | 0 | Yes | No |
| 16393113 | CATHETER | April 2019 | November 2023 | Allow | 55 | 2 | 0 | No | Yes |
| 16388782 | SYSTEMS AND METHODS FOR A TELESCOPING DRAINAGE CATHETER AND ASSOCIATED LOCKING MECHANISMS | April 2019 | December 2023 | Abandon | 55 | 2 | 1 | Yes | No |
| 16337346 | METHODS AND SYSTEMS FOR TREATING HYDROCEPHALUS | March 2019 | March 2024 | Allow | 59 | 3 | 0 | Yes | Yes |
| 16315499 | GLAUCOMA TREATMENT DEVICES AND METHODS | January 2019 | July 2022 | Abandon | 42 | 0 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner STRACHAN, KATE ELIZABETH.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 66.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner STRACHAN, KATE ELIZABETH works in Art Unit 3781 and has examined 60 patent applications in our dataset. With an allowance rate of 35.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 38 months.
Examiner STRACHAN, KATE ELIZABETH's allowance rate of 35.0% places them in the 3% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by STRACHAN, KATE ELIZABETH receive 2.12 office actions before reaching final disposition. This places the examiner in the 71% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by STRACHAN, KATE ELIZABETH is 38 months. This places the examiner in the 13% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +33.2% benefit to allowance rate for applications examined by STRACHAN, KATE ELIZABETH. This interview benefit is in the 84% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 18.2% of applications are subsequently allowed. This success rate is in the 10% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 1% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 99% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 80.0% are granted (fully or in part). This grant rate is in the 92% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 42% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.